→ In 31.12.2021, after 3 years of success, the Hellenic Precision Medicine Network in Ontology ceased its operations.
The Hellenic Network of Precision Medicine on Cancer was founded on 17/05/2018 at the initiative of the Research and Innovation Department of the Ministry of Education, Research and Religion in close collaboration with the Ministry of Health.
The Network is funded by the Framework of the Hellenic Republic – Siemens Settlement Agreement.
PATIENTS
5527 medical examinations until 31/10/2021
―
improved outlook and quality of life
―
collaboration with the Hellenic Cancer Federation
HEALTHCARE SYSTEM
standardization of procedures, completion of inter-laboratory checks
–
review of 7 reference laboratories
–
upgrade of clinical practices and promotion of digitized health
–
modern e-Referrals system, database, national repository for cancer genomic data
BIOSCIENTISTS
development of new tools and workflows, institutional framework for research studies
―
new prospects for research and cooperation through access to a large volume of biodata. Collaboration with: Hellenic Society of Medical Oncology (HeSMO), Hellenic Society of Haematology, Hellenic Society of Pathology.
WORK AND EDUCATION
45 new highly skilled job positions
―
appealing motives for Greek scientists living abroad
―
development of new specializations in Biology, Bioinformatics and Pharmacology
―
utilization of graduate students and motivation to attract teaching staff from abroad
INDUSTRY
Development of software and advanced diagnostic products. Collaboration interest from Biotechnology companies and diagnostic lab (e.g.):
ΑΝΤΙΣΕΛ ΑΕ
SafeBlood Bioanalytica
ΒΑΡΕΛΑΣ ΑΕ
GENEKOR
ΓΕΝΟΤΥΠΟΣ
PHARMACEUTICAL INDUSTRY
institutional framework for cooperation
―
collaboration in real-world clinical practices and early-access projects. For example:
Pharma Innovation Forum
Janssen
Novartis
Gilead
Abbvie
Roche
Astrazeneca